GlassScriptPhysician profile
Rajesh T Patel
NPI 1851585863
$11,231.45
in general payments reported to CMS, 2019-2025
30 companies · $923 in 2025
The $923 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $655 · 2021: $406 · 2022: $492 · 2023: $7,053 · 2024: $1,317 · 2025: $923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,336 · Food and Beverage: $2,946 · Travel and Lodging: $2,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,336.00 |
| Food and Beverage | $2,945.99 |
| Travel and Lodging | $2,011.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $6,668.81 | 2021-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $643.77 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $624.82 | 2019-2025 | Farxiga, Breztri, Lokelma |
| Lilly USA, LLC | $592.23 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $389.06 | 2019-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $302.28 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $269.17 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $264.45 | 2019-2024 | Verquvo, Delstrigo, Dificid |
| Janssen Pharmaceuticals, INC | $243.86 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $224.05 | 2023-2024 | Watchman Flx, Embold Fibered |
| Pfizer INC. | $200.25 | 2019-2025 | |
| Exact Sciences Corporation | $173.29 | 2023-2025 | Cologuard Collection Kit |
| Tela Bio, INC. | $98.13 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $91.77 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $73.12 | 2020-2025 | Xifaxan |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $55.42 | 2019 | |
| Amarin Pharma, INC. | $53.07 | 2020-2021 | |
| Amgen INC. | $37.03 | 2025 | Repatha |
| Daiichi Sankyo INC. | $26.11 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $25.72 | 2020-2022 | |
| Emmaus Medical, INC. | $23.19 | 2022 | |
| Cequr Corporation | $21.57 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.49 | 2024 | Caplyta |
| Sanofi-Aventis U.S. LLC | $17.68 | 2025 | |
| Xeris Pharmaceuticals, INC. | $17.65 | 2024 | Gvoke Hypopen |
| Renalytix Ai, INC. | $17.33 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Bard Peripheral Vascular, INC. | $17.11 | 2025 | Covera |
| Sunovion Pharmaceuticals INC. | $14.74 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $14.14 | 2021 | |
| Shield Therapeutics INC | $13.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.